Barbara Milczarek for The World of Pharmaceutical Industry Magazine!
In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.
In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.
We invite you to read the full article in polish.
Dr. Magdalena Tagowska is yet another expert from our firm recommended in the latest IAM Czytaj dalej
The changes in the judicial system concerning intellectual property matters have been widely discussed for Czytaj dalej
As it befits the jubilee, the hundredth Pharmaceutical Trade Mark Group (PTMG) Conference was filled Czytaj dalej
